Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 4:43 pm Purchase | 13G | LEXEO THERAPEUTICS INC LXEO | Longitude Capital Partners IV LLC | 2,567,100 9.6% | 2,567,100 (New Position) | View |
| 2024-02-05 4:45 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Longitude Capital Partners IV LLC | 5,164,062 9.8% | 9,925 (+0.19%) | View |
| 2024-02-05 4:40 pm Purchase | 13G | CG ONCOLOGY INC CGON | Longitude Capital Partners IV LLC | 4,662,281 7% | 4,662,281 (New Position) | View |
| 2023-02-16 4:40 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Longitude Capital Partners IV LLC | 5,154,137 12.3% | 1,714,285 (+49.84%) | View |
| 2022-04-05 07:36 am Purchase | 13D | VERA THERAPEUTICS INC VERA | Longitude Capital Partners IV LLC | 3,439,852 12.7% | 343,258 (+11.09%) | View |
| 2021-05-27 4:45 pm Sale | 13D | EARGO INC EAR | Longitude Capital Partners IV LLC | 2,923,703 4.9% | -4,444 (-0.15%) | View |
| 2021-05-27 4:32 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Longitude Capital Partners IV LLC | 3,096,594 15.1% | 3,096,594 (New Position) | View |
| 2021-04-26 4:55 pm Sale | 13D | EARGO INC EAR | Longitude Capital Partners IV LLC | 2,928,147 7.6% | -991,655 (-25.30%) | View |
| 2020-10-30 4:24 pm Purchase | 13D | EARGO INC EAR | Longitude Capital Partners IV LLC | 3,919,802 10.5% | 3,919,802 (New Position) | View |